IFN-alpha 2b

IFN-alpha 2b

IFN-alpha 2b Informations sur la molécule

Molecule Name
Interferon alpha-2
Alias de la molécule
IFN-alpha 2b,IFNA2B,IFN-alpha 2 (alpha 2b),interferon alpha 2b
Drug Development Progress
Nombre de médicaments cliniques10
Nombre de médicaments commercialisés1
Phase de R&D la plus avancéeApproved
Alias de la cible
IFNA2B,IFNA2C,LeIF A,Interferon alpha-2,IFN-alpha-2,IFNA2,Interferon Alpha 2,Alpha-2a Interferon,Interferon Alpha 2b,Interferon Alpha A,Interferon Alpha 2a,Interferon Alpha-A,IFN-AlphaA,IFNA2A,INFA2,IFNA
Contexte de la molécule
IFN-alpha is a cytokine that has an immunomodulatory function. It plays an important role not only in antiviral activity but also in several physiologic functions, such as activation of dendritic cells and accelerated expression of major histocompatibility complex I and II molecules that may cause increased antigen presentation. Variants of human leukocyte interferon alpha 2 (IFN-alpha 2a, alpha 2b, and alpha 2c) differ from each other by changes in their coding regions at nucleotide positions 137 and 170. IFN-alpha 2b (IFNα-2b) is an important cytokine and used for antiviral and anticancer treatment.

IFN-alpha 2b Liste de produits

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Informations sur les médicaments cliniques

Nom anglaisCode de recherchePhase de R&DEntrepriseIndicationEssai clinique
Autologous CD34+-enriched hematopoietic stem and progenitor cells (Genenta Science)Phase 2 ClinicalGenenta Science Srl
Carcinoma, Renal Cell; Glioblastoma; Multiple Myeloma
Details
NG-641EnAd-FAP-BiTE; EnAd-FAP-Tac; NG-641; NG-aFAPPhase 1 ClinicalAkamis Bio Ltd
Neoplasm Metastasis; Neoplasms, Glandular and Epithelial; Squamous Cell Carcinoma of Head and Neck
Details
recombinant human serum albumin-interferon-alpha-2a fusion protein (Qilu Pharmaceutical)Phase 1 ClinicalQilu Pharmaceutical Co Ltd
Hepatitis B
Details
Q101-pegylated interferon alfa-2a (CSPC Zhongqi Pharmaceutical Technology)Phase 1 ClinicalCSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd
Hepatitis B, Chronic
Details
PEGylated interferon alpha-1b (Shanghai Institute of Biological Products)Phase 1 ClinicalShanghai Institute of Biological Products Co Ltd
Hepatitis B; Neoplasms; Varicella Zoster Virus Infection
Details
SFR-1882SFR-1882Phase 1 ClinicalTianjin Sinobiotech Ltd
Anemia; Renal Insufficiency
Details
CX-801CX-801Phase 1 ClinicalCytomx Therapeutics Inc
Carcinoma, Renal Cell; Melanoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck
Details
ORB-011ORB-011Phase 1 Clinical
Neoplasms; Solid tumours
Details
interferon alfa-2b follow-on biologic (Amoytop)ClinicalXiamen Amoytop Biotech Co Ltd
Condylomata Acuminata; Hepatitis B; Hepatitis C; Leukemia, Hairy Cell; Lymphoma, Follicular; Melanoma; Sarcoma, Kaposi
Details
interferon-alpha2b (The University Health Network)ClinicalUniversity Health Network (Uhn)
Coronavirus Disease 2019 (COVID-19)
Details

Informations sur les médicaments commercialisés

Nom anglaisCode de recherchePhase de R&DEntreprisePlus ancien nom de marquePays d'approbation le plus ancienIndication la plus ancienneSociété d'approbation la plus ancienneDate d'approbation la plus ancienneIndicationEssai clinique
Nadofaragene firadenovecSCH-721015; FE-999326; SCH-209702/SCH-721015; SCH-721015/SCH-209702; TR-002ApprovedFkd Therapies, Schering-Plough Labo NvInstiladrin, AdstiladrinUnited StatesUrinary Bladder NeoplasmsFerring Pharmaceuticals A/S2022-12-16
Adenocarcinoma; Carcinoma, Transitional Cell; Mesothelioma; Pancreatic Neoplasms; Solid tumours; Urinary Bladder Neoplasms
Details